Revised estimates reflect a declining sentiment towards Kornit Digital, with substantial cuts to both revenue and EPS forecasts suggesting operational issues despite its anticipated faster-than-industry growth.
Gainers: •$Resolute Forest Products(RFP.US)$+65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right) •$Applied Molecular(AMTI.US)$+2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101) •$プライモリス サービシズ(PRIM.US)$+2.1% (awarded a $170 mln project by Texas DOT) •$バイオジェン(BIIB.US)$+2.1% (Bi...
Greenback Stocks :
economy typically turns to tech to innovate out of slumps. but tech is being punished. what other tech can we rely? crypto! its been stable since August and we might see growth soon. keep eye on $ビットコイン (BTC.CC)$ and $イーサリアム (ETH.CC)$ and lunac. $Terra (LUNA.CC)$ investing in crytpo will eventually turn around tech and our economy. mark cuban was right!
コーニット デジタルに関するコメント
In reaction to earnings/guidance:
• $トレードデスク A(TTD.US)$+17%, $ワーキバ(WK.US)$ +15.3%, $アーロ テクノロジーズ(ARLO.US)$ +12%, $アレイ テクノロジーズ(ARRY.US)$ +10.3%, $エバーブリッジ(EVBG.US)$ +9.7%, $カタリスト ファーマシューティカルズ(CPRX.US)$ +9.4%, $ハロザイムセラピューティクス(HALO.US)$ +8.7%, $ヴェロ3D(VLD.US)$ +7.6%, $サイバーアーク ソフトウェア(CYBR.US)$ + 6.2%, $ヘモネティクス(HAE.US)$ +5.8%, $ジャクソン フィナンシャル A(JXN.US)$ +5.7% (also increases dividend), $アクソン エンタープライズ(AXON.US)$ +4.8%,...
• $ヴァーティカル エアロスペース(EVTL.US)$ +46.2% (FLYINGGROUP, one of Europe’s leading business jet operators, has conditionally pre-ordered up to 50 VX4 aircraft)
• $ピンタレスト A(PINS.US)$ +15% (activist Elliott Mgmt has built a 9+% stake, according to WSJ)
• $シティグループ(C.US)$ +4.6% (Citigroup Q2 EPS $2.19 Beats $1.69 Estimate, Sales $19.60B Beat $18.12B Estimate)
• $レッド ロビン グルメ バーガーズ(RRGB.US)$ +3.2% (names new CEO)
• $ネクスジェル エナジー(NXE.US)$ +2...
• $Resolute Forest Products(RFP.US)$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular(AMTI.US)$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $プライモリス サービシズ(PRIM.US)$ +2.1% (awarded a $170 mln project by Texas DOT)
• $バイオジェン(BIIB.US)$ +2.1% (Bi...
まだコメントはありません